BioCentury
ARTICLE | Clinical News

Sialanar glycopyrronium bromide regulatory update

August 8, 2016 7:00 AM UTC

EMA’s CHMP recommended approval of Sialanar glycopyrronium bromide from Proveca to treat persistent drooling and excessive salivation in children and adolescents with neurological conditions. The reco...